EFDID: 134580EFD: View Filing

Issuer: AntriaBio, Inc. (0001509261) - D

Accession: 0001140361-15-002749 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
  • Entity Name:
    AntriaBio, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2010)
  • Address:
    1450 Infinite Drive
    Louisville, CO 80027
  • Persons:
    Related Persons 5
    Nevan Charles Elam
    Executive Officer, Director
    Hoyoung Huh
    Director, Executive Officer
    Sankaram Mantripragada
    Executive Officer
    Morgan Lynn Fields
    Executive Officer
    Barry Sherman
    Director
EDGAR: Offering Information
  • Accession Date:
    01/26/2015
  • First Sale Date:
    11/28/2014
  • Offering Amount:
    $35,270,270
  • Amount Sold:
    $6,925,580
  • Amount Remaining:
    $28,344,690
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity, Unit = 1 common share and 1 common share purchase warrant.
  • Sales Clarification:
    Aggregate offering includes amount that may be received by Issuer upon exercise of warrants. Each warrant may be exercised for 1 common share at a price of $2.50 per share for a period of 36 months from date of issuance.
EFD: Current State Notices

Notices found in EFD

Filed:NJ, PA, TX, WI
Inactive:GA, IL, NV, OH, WA
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Paulson Investment Company, Inc. 5670 None None CA, CT, FL, GA, IL, MI, MN, NJ, NY, PA, TX, WA, MA, NV, WI, OH
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
AntriaBio, Inc./s/ Morgan Lynn FieldsMorgan Lynn FieldsChief Accounting Officer2014-01-22